Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer’s disease patients in APOE ɛ4 carriers. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.